The Transplant Genomics brand, founded in 2013 (United States), from 90 sister brands and 2617 competing brands. Transplant Genomics is owned by EUROFINS SCIENTIFIC SE, listed on the stock exchange of Paris Its International Securities Identification Number (ISIN) is FR0014000MR3. The sector of Transplant Genomics is Medical Diagnostics & Research.
Investment simulator :
Portfolio valuation
EUROFINS SCIENTIFIC SE
(Transplant Genomics)
over 5 years*
EUR 93.27